Resumen
The treatment of immune-mediated hemolytic anemia (IHA) complicating hem atopoietic stem cell transplantation (HSCT) is often unsatisfactory. We report a case of IHA which occurred after T-and B-cell depleted unrelated donor HSCT carried out for mucopolysaccharidosis type I-H (Hurler syndrome) which was successfully treated with anti-CD20+ monoclonal antibody.
| Idioma original | Inglés |
|---|---|
| Páginas (desde-hasta) | 43-45 |
| Número de páginas | 3 |
| Publicación | Acta Haematologica |
| Volumen | 109 |
| N.º | 1 |
| DOI | |
| Estado | Publicada - 2003 |
| Publicado de forma externa | Sí |
Huella
Profundice en los temas de investigación de 'Rituximab for immune hemolytic anemia following T- and b-cell-depleted hematopoietic stem cell transplantation'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver